Abstract LB056: IBI334, a Novel ADCC-enhanced B7-H3/EGFR Bispecific Antibody, Demonstrated Potent Pre-Clinical Efficacy in Solid Tumors
Cancer Research(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined